Carprieve 50 mg/ml Solution recalled over impurity concerns
The VMD has issued a product defect recall alert for Carprieve 50 mg/ml Solution for Injection for Cattle.
The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Carprieve 50 mg/ml Solution for Injection for Cattle, manufactured by Norbrook Laboratories Ltd.
In a press release, the VMD writes: 'We wish to make veterinary surgeons aware that Norbrook Laboratories Ltd has issued a recall for the product Carprieve 50 mg/ml Solution for Injection for Cattle as a precautionary measure.
'During stability monitoring analysis of the product, an impurity was detected which exceeded the specification for an individual impurity. The impurity was isolated, and the best estimate of identity indicated that the impurity is carprofen related.
'The problem affects a limited number of batches and is identifiable through quality control testing. The concentration of the process impurity does not increase over time'
The recall affects the following batch numbers only:
9371-90
9372-90
9373-91
0105-90
In light of this recall, Norbrook Laboratories is in the process of contacting wholesale dealers and veterinary surgeons to examine inventory immediately and quarantine products.
Further information regarding the recall can be obtained from Mr Gary Mckee on 0044 2830 264435 or by email to gary.mckee@norbrook.co.uk
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
